XML 17 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Shareholders' Deficit - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Beginning balance (in shares) at Jan. 02, 2021   25,390    
Beginning balance at Jan. 02, 2021 $ (223,978) $ 254 $ 0 $ (224,232)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 66,634     66,634
Exercise of common stock options (in shares)   106    
Exercise of common stock options 2,460 $ 1 2,459  
Stock-based compensation (in shares)   314    
Stock-based compensation 6,416 $ 3 6,413  
Repurchases of common stock (in shares)   (1,346)    
Repurchases of common stock (184,182) $ (13) (8,872) (175,297)
Ending balance (in shares) at Apr. 03, 2021   24,464    
Ending balance at Apr. 03, 2021 (332,650) $ 245 0 (332,895)
Beginning balance (in shares) at Jan. 02, 2021   25,390    
Beginning balance at Jan. 02, 2021 (223,978) $ 254 0 (224,232)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 142,605      
Ending balance (in shares) at Oct. 02, 2021   22,647    
Ending balance at Oct. 02, 2021 (440,066) $ 226 0 (440,292)
Beginning balance (in shares) at Apr. 03, 2021   24,464    
Beginning balance at Apr. 03, 2021 (332,650) $ 245 0 (332,895)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 22,250     22,250
Exercise of common stock options (in shares)   35    
Exercise of common stock options 1,075   1,075  
Stock-based compensation (in shares)   22    
Stock-based compensation 5,969   5,969  
Repurchases of common stock (in shares)   (899)    
Repurchases of common stock (100,302) $ (9) (7,044) (93,249)
Ending balance (in shares) at Jul. 03, 2021   23,622    
Ending balance at Jul. 03, 2021 (403,658) $ 236 0 (403,894)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 53,721     53,721
Exercise of common stock options (in shares)   10    
Exercise of common stock options 312   312  
Stock-based compensation (in shares)   19    
Stock-based compensation 7,316   7,316  
Repurchases of common stock (in shares)   (1,004)    
Repurchases of common stock (97,757) $ (10) (7,628) (90,119)
Ending balance (in shares) at Oct. 02, 2021   22,647    
Ending balance at Oct. 02, 2021 $ (440,066) $ 226 0 (440,292)
Beginning balance (in shares) at Jan. 01, 2022 22,683 22,683    
Beginning balance at Jan. 01, 2022 $ (424,953) $ 227 3,971 (429,151)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 2,074     2,074
Exercise of common stock options (in shares)   21    
Exercise of common stock options 531   531  
Stock-based compensation (in shares)   341    
Stock-based compensation 4,133 $ 3 4,130  
Repurchases of common stock (in shares)   (813)    
Repurchases of common stock (50,998) $ (8) (8,632) (42,358)
Ending balance (in shares) at Apr. 02, 2022   22,232    
Ending balance at Apr. 02, 2022 $ (469,213) $ 222 0 (469,435)
Beginning balance (in shares) at Jan. 01, 2022 22,683 22,683    
Beginning balance at Jan. 01, 2022 $ (424,953) $ 227 3,971 (429,151)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income $ 42,040      
Ending balance (in shares) at Oct. 01, 2022 22,001 22,001    
Ending balance at Oct. 01, 2022 $ (437,471) $ 220 458 (438,149)
Beginning balance (in shares) at Apr. 02, 2022   22,232    
Beginning balance at Apr. 02, 2022 (469,213) $ 222 0 (469,435)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 34,933     34,933
Exercise of common stock options (in shares)   2    
Exercise of common stock options 54   54  
Stock-based compensation (in shares)   26    
Stock-based compensation 3,910 $ 1 3,909  
Repurchases of common stock (in shares)   (296)    
Repurchases of common stock (12,646) $ (3) (3,963) (8,680)
Ending balance (in shares) at Jul. 02, 2022   21,964    
Ending balance at Jul. 02, 2022 (442,962) $ 220 0 (443,182)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 5,033     5,033
Exercise of common stock options (in shares)   19    
Exercise of common stock options 413   413  
Stock-based compensation (in shares)   30    
Stock-based compensation 542   542  
Repurchases of common stock (in shares)   (12)    
Repurchases of common stock $ (497)   (497)  
Ending balance (in shares) at Oct. 01, 2022 22,001 22,001    
Ending balance at Oct. 01, 2022 $ (437,471) $ 220 $ 458 $ (438,149)